Abstract 2111P
Background
Psychometric assessment tools are widely available but underutilized in daily oncology practice. The aim of this study was to evaluate the role of multiple psychometric scales in identifying cancer patients in distress who need Psycho-Oncology management.
Methods
Colorectal cancer patients were prospectively asked to complete a survey including 3 psychometric scales (GAD-7, PHQ-9, PC-PTSD-5). Those scoring high on at least one scale (GAD-7 score ≥ 10, PHQ-9 score ≥ 10, PC-PTSD-5 score ≥ 4) were offered referral to the Psycho-Oncology service. Those accepting the referral were further triaged by members of this service via a standardized semi-structured interview. Patients were divided into three groups: those accepted by the Psycho-Oncology service, those declined the referral and those discharged from the service with no need for further intervention. Outcomes were compared with the analysis of variance test (ANOVA).
Results
Fifty-four patients (30 females) of median age 60 years (range 36-81) were prospectively evaluated. 20 patients (37%) reported their cancer was under control, 15 (28%) believed they had progressive disease, while 19 (35%) were uncertain. Approximately half patients (26; 48%) referred a prior history of a mental condition. The mean (±SE) scores for each psychometric scale were 10.96 (± 0.78), 12.79 (± 0.82), and 1.07 (± 0.21), respectively for GAD-7, PHQ-9, PC-PTSD-5. Thirty-four patients (63%) scored high on GAD-7, 40 (74%) on PHQ-9 and 8 (15%) on PC-PTSD-5. Almost half of the patients declined a referral (25, 46%), 22 (41%) were assessed by a Psycho-Oncologist and managed accordingly and 7 (13%) were discharged after the initial tirage. There was no statistically significant difference in the mean psychometric scores between the three identified groups (p<0.05).
Conclusions
Psychometric scales are useful screening tools to identify distress but cannot differentiate between general distress and psychological/psychiatric symptoms requiring specialist intervention. Psychometric scales should be used in conjunction with semi-structured interviews. The ‘screen and triage’ model should be further investigated as part of an integrated care model, to signpost cancer patients to appropriate support services.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Servier.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2045P - Patient Reported Outcome Measures (PROMs) capturing therapy adherence of cancer patients: A systematic literature review
Presenter: Luise Richter
Session: Poster session 06
2046P - The importance of communicating bad news in medical education
Presenter: Georgios Goumas
Session: Poster session 06
2047P - Neutrop: A descriptive, observational study for G-CSF prescription in daily practice
Presenter: Florian Scotté
Session: Poster session 06
2048P - Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
Presenter: Lotte Hulskotte
Session: Poster session 06
2049P - Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
Presenter: Gisele Moreira
Session: Poster session 06
2050P - Integrating ayurveda herbs with standard of care for management of cancer or cancer treatment related anorexia
Presenter: Yogesh Bendale
Session: Poster session 06
2051P - E-PRO within comprehensive companion program for patients undergoing systemic cancer treatment to reduce emergency visits and inpatient admission in a Peruvian institution
Presenter: Patricia Rioja Viera
Session: Poster session 06
2052P - Adverse events in FLOT chemotherapy for locally advanced gastric cancer: An observational study of pre- and post-operative toxicity profiles
Presenter: Camila Oliveira
Session: Poster session 06
2053P - Dehospitalization through outpatient drug release in clinical pharmacy as a strategic cost-minimization action in a public oncology hospital in the Eastern Amazon: A quantitative analysis
Presenter: Kalysta Borges
Session: Poster session 06
2054P - Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Presenter: Colin Vercueil
Session: Poster session 06